Hillenbrand (HI) completed the sale of its majority interest in the Milacron injection molding and extrusion business to Bain Capital for $287 million.
Proceeds will be used to pay down debt, Hillenbrand said Monday in a statement.
"This transaction reflects the continued transformation of Hillenbrand's portfolio mix as a pure-play industrial company," Chief Executive Officer Kim Ryan said in the statement.
Bain now own 51% of Milacron, and Hillenbrand has 49%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。